4-36091909-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_015230.4(ARAP2):c.4397G>A(p.Gly1466Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000162 in 1,604,888 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_015230.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ARAP2 | NM_015230.4 | c.4397G>A | p.Gly1466Glu | missense_variant | 28/33 | ENST00000303965.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ARAP2 | ENST00000303965.9 | c.4397G>A | p.Gly1466Glu | missense_variant | 28/33 | 1 | NM_015230.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 152014Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000360 AC: 9AN: 250028Hom.: 0 AF XY: 0.0000296 AC XY: 4AN XY: 135162
GnomAD4 exome AF: 0.00000688 AC: 10AN: 1452874Hom.: 0 Cov.: 30 AF XY: 0.00000831 AC XY: 6AN XY: 722074
GnomAD4 genome AF: 0.000105 AC: 16AN: 152014Hom.: 0 Cov.: 32 AF XY: 0.0000539 AC XY: 4AN XY: 74246
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 06, 2022 | The c.4397G>A (p.G1466E) alteration is located in exon 28 (coding exon 27) of the ARAP2 gene. This alteration results from a G to A substitution at nucleotide position 4397, causing the glycine (G) at amino acid position 1466 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at